Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q6D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Vyndamax 61 mg capsule unit dose packages (30 count) with a contract value of $14,592.57 and an ultimate completion date of January 28, 2026. This is a firm fixed-price, non-set-aside delivery order supporting the DLA's medical supply chain. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Vyndamax is a pharmaceutical treatment used in the management of cardiac amyloidosis, reflecting the DLA's procurement of specialized medications for military healthcare programs.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive global pharmaceutical support vehicle enables Cencora and its subsidiaries to supply an extensive range of pharmaceutical products, medical devices, vaccines, and medical supplies to support military healthcare systems worldwide. The IDC demonstrates the contractor's established capability to fulfill federal procurement requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9Q6D?
SPE2DR26F9Q6D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9Q6D worth?
The government has obligated $14,593 on SPE2DR26F9Q6D.
Is contract SPE2DR26F9Q6D an order under another contract?
Yes. SPE2DR26F9Q6D is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q6D competed?
The extent of competition for SPE2DR26F9Q6D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award